Biogen Reports Third-Quarter Revenue of $2.8 Billion

Biogen reported third-quarter 2026 revenue of $2.8B, up 10.6% from the prior-year quarter, while it recorded a net loss of $20.6M compared with net income of $466.5M a year earlier. Growth in rare disease and newly acquired immunology products helped offset continued declines in multiple sclerosis…